Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 4
1989 1
1990 2
1992 1
1994 1
1995 1
1997 1
1998 1
2009 1
2011 1
2017 1
2018 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe.
Jung A, Orenti A, Dunlevy F, Aleksejeva E, Bakkeheim E, Bobrovnichy V, Carr SB, Colombo C, Corvol H, Cosgriff R, Daneau G, Dogru D, Drevinek P, Vukic AD, Fajac I, Fox A, Fustik S, Gulmans V, Harutyunyan S, Hatziagorou E, Kasmi I, Kayserová H, Kondratyeva E, Krivec U, Makukh H, Malakauskas K, McKone EF, Mei-Zahav M, de Monestrol I, Olesen HV, Padoan R, Parulava T, Pastor-Vivero MD, Pereira L, Petrova G, Pfleger A, Pop L, van Rens JG, Rodic M, Schlesser M, Storms V, Turcu O, Woz Niacki L, Yiallouros P, Zolin A, Downey DG, Naehrlich L. Jung A, et al. Among authors: kayserova h. ERJ Open Res. 2021 Dec 27;7(4):00411-2021. doi: 10.1183/23120541.00411-2021. eCollection 2021 Oct. ERJ Open Res. 2021. PMID: 34984210 Free PMC article.
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020.
Naehrlich L, Orenti A, Dunlevy F, Kasmi I, Harutyunyan S, Pfleger A, Keegan S, Daneau G, Petrova G, Tješić-Drinković D, Yiallouros P, Bilkova A, Olesen HV, Burgel PR, Parulava T, Diamantea F, Párniczky A, McKone EF, Mei-Zahav M, Salvatore M, Colombo C, Aleksejeva E, Malakauskas K, Schlesser M, Fustik S, Turcu O, Zomer-van Ommen D, Wathne AS, Woźniacki Ł, Pereira L, Pop L, Kashirskaya N, Rodić M, Kayserova H, Krivecs U, Mondejar-Lopez P, de Monestrol I, Dogru D, Makukh H, Cosgriff R, van Koningsbruggen-Rietschel S, Jung A; European Cystic Fibrosis COVID project group. Naehrlich L, et al. Among authors: kayserova h. J Cyst Fibros. 2021 Jul;20(4):566-577. doi: 10.1016/j.jcf.2021.03.017. Epub 2021 Apr 18. J Cyst Fibros. 2021. PMID: 34016559 Free PMC article.
[Nocturnal asthma].
Cervenka J, Hruskovic I, Kayserová H. Cervenka J, et al. Among authors: kayserova h. Cesk Pediatr. 1989 Aug;44(8):469-72. Cesk Pediatr. 1989. PMID: 2791099 Slovak. No abstract available.
Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results.
Dorfman R, Li W, Sun L, Lin F, Wang Y, Sandford A, Paré PD, McKay K, Kayserova H, Piskackova T, Macek M, Czerska K, Sands D, Tiddens H, Margarit S, Repetto G, Sontag MK, Accurso FJ, Blackman S, Cutting GR, Tsui LC, Corey M, Durie P, Zielenski J, Strug LJ. Dorfman R, et al. Among authors: kayserova h. Hum Genet. 2009 Dec;126(6):763-78. doi: 10.1007/s00439-009-0724-8. Hum Genet. 2009. PMID: 19662435 Free PMC article.
[Present views on the regulation of IgE synthesis].
Hruskovic I, Páleníková O, Brezina M, Kayserová H. Hruskovic I, et al. Among authors: kayserova h. Cesk Pediatr. 1990 May;45(5):279-82. Cesk Pediatr. 1990. PMID: 2249294 Review. Slovak. No abstract available.
Magnetic resonance imaging in diagnosis of potential arthropathogenicity in children receiving quinolones. No evidence of quinolone-induced arthropathy.
Danisovicová A, Krcméryová T, Belan S, Kayserová H, Hruskovic I, Brezina M, Kaiserová E, Rovensky T, Dluholucky S, Krcméry V Jr. Danisovicová A, et al. Among authors: kayserova h. Drugs. 1995;49 Suppl 2:492-4. doi: 10.2165/00003495-199500492-00146. Drugs. 1995. PMID: 8549412 Clinical Trial. No abstract available.
17 results